In summary, our study uncovers a previously unrecognized stromal mechanism of resistance in melanoma: collagen‐rich ECM remodeling during residual disease physically excludes CD8+ T cells, enabling tumor persistence and subsequent relapse. Here, CD8A is linked to melanoma.